Qube Research & Technologies (QRT) Portfolio holdings
Qube Research & Technologies (QRT) is a British investment firm that trades with computer-driven models and began life inside Credit Suisse. It started in late 2016 as the Qube Fund, run by the bank's asset management unit for model-based strategies, and used computer models to trade stocks. Credit Suisse planned to spin the fund off because rules such as the Volcker Rule restricted banks from trading with their own money, and at the start of 2018 its management team bought the unit and renamed it Qube Research & Technologies. It runs a mix of strategies across many regions, asset classes and time horizons, with research teams of engineers, physicists, mathematicians, data scientists and fundamental analysts.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$1.31B |
| 2 |
NVIDIA
NVDA
|
+$1.03B |
| 3 |
Meta Platforms (Facebook)
META
|
+$840M |
| 4 |
Shopify
SHOP
|
+$815M |
| 5 |
Caterpillar
CAT
|
+$639M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1B |
| 2 |
Chevron
CVX
|
+$834M |
| 3 |
Sandisk
SNDK
|
+$632M |
| 4 |
Intercontinental Exchange
ICE
|
+$490M |
| 5 |
ExxonMobil
XOM
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.18% |
| 2 | Technology | 19.85% |
| 3 | Financials | 12.83% |
| 4 | Industrials | 10.55% |
| 5 | Healthcare | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2151
CALL
SAP
SAP
$271B
| $2.71M | ﹤0.01% |
13,000
-1,300
| -9% | -$252K |
2025 Q2
5 quarters
|
|
2152
CALL
Northrop Grumman
NOC
$78.2B
| $2.71M | ﹤0.01% |
5,600
-1,000
| -15% | -$538K |
2024 Q2
9 quarters
|
|
2153
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.5B
| $2.7M | ﹤0.01% |
27,763
-29,167
| -51% | -$2.86M |
2021 Q3
20 quarters
|
|
2154
Towne Bank
TOWN
$3.36B
| $2.7M | ﹤0.01% |
75,651
-298,511
| -80% | -$11.1M |
2023 Q2
13 quarters
|
|
2155
Digi International
DGII
$2.1B
| $2.7M | ﹤0.01% |
+35,369
| New | +$2.57M |
2026 Q3
0 quarters
|
|
2156
iShares Future AI & Tech ETF
ARTY
$3.49B
| $2.7M | ﹤0.01% |
+34,421
| New | +$2.51M |
2026 Q3
0 quarters
|
|
2157
Fennec Pharmaceuticals
FENC
$410M
| $2.69M | ﹤0.01% |
252,940
+194,648
| +334% | +$2.14M |
2025 Q4
3 quarters
|
|
2158
PUT
Halliburton
HAL
$27.9B
| $2.69M | ﹤0.01% |
84,700
-108,800
| -56% | -$3.71M |
2024 Q3
8 quarters
|
|
2159
Schwab US Large-Cap Value ETF
SCHV
$15.8B
| $2.69M | ﹤0.01% |
80,804
+56,049
| +226% | +$1.93M |
2022 Q1
18 quarters
|
|
2160
Assembly Biosciences
ASMB
$432M
| $2.69M | ﹤0.01% |
114,422
+62,934
| +122% | +$1.8M |
2025 Q3
4 quarters
|
|
2161
Vanguard Real Estate ETF
VNQ
$38.6B
| $2.69M | ﹤0.01% |
29,962
+14,312
| +91% | +$1.39M |
2026 Q2
1 quarter
|
|
|
2162
State Street SPDR S&P 500 ETF Trust
SPY
$800B
| $2.68M | ﹤0.01% |
3,519
-1,319,130
| -100% | -$1B |
2026 Q2
1 quarter
|
|
2163
AXT Inc
AXTI
$2.75B
| $2.68M | ﹤0.01% |
+34,620
| New | +$2.23M |
2026 Q3
0 quarters
|
|
2164
Structure Therapeutics
GPCR
$1.43B
| $2.67M | ﹤0.01% |
85,415
-7,988
| -9% | -$375K |
2026 Q1
2 quarters
|
|
2165
Zymeworks
ZYME
$1.85B
| $2.67M | ﹤0.01% |
100,652
-492,938
| -83% | -$12.8M |
2025 Q2
5 quarters
|
|
2166
iShares MSCI USA Quality GARP ETF
GARP
$3.48B
| $2.65M | ﹤0.01% |
31,057
+25,550
| +464% | +$2.1M |
2026 Q2
1 quarter
|
|
2167
PUT
Wayfair
W
$15.3B
| $2.65M | ﹤0.01% |
25,800
-300
| -1% | -$29.3K |
2024 Q4
7 quarters
|
|
2168
PUT
State Street Consumer Staples Select Sector SPDR ETF
XLP
$15.1B
| $2.64M | ﹤0.01% |
32,800
+20,000
| +156% | +$1.69M |
2025 Q2
5 quarters
|
|
2169
U.S. High Relative Profitability Portfolio ETF Class Shares
DUHP
$12.9B
| $2.64M | ﹤0.01% |
62,920
-21,567
| -26% | -$905K |
2023 Q4
11 quarters
|
|
2170
CALL
Danaher
DHR
$164B
| $2.64M | ﹤0.01% |
11,900
-4,000
| -25% | -$821K |
2024 Q3
8 quarters
|
|
2171
ProShares UltraPro Dow 30
UDOW
$860M
| $2.62M | ﹤0.01% |
41,610
+38,151
| +1,103% | +$2.7M |
2026 Q2
1 quarter
|
|
2172
Fluence Energy
FLNC
$670M
| $2.61M | ﹤0.01% |
340,017
-198,952
| -37% | -$2.42M |
2025 Q4
3 quarters
|
|
|
2173
CALL
Halliburton
HAL
$27.9B
| $2.61M | ﹤0.01% |
82,100
-18,400
| -18% | -$627K |
2024 Q3
8 quarters
|
|
2174
iShares Asia 50 ETF
AIA
$4.46B
| $2.61M | ﹤0.01% |
18,352
+12,425
| +210% | +$1.71M |
2026 Q1
2 quarters
|
|
2175
CALL
Etsy
ETSY
$7.67B
| $2.6M | ﹤0.01% |
36,400
-2,300
| -6% | -$182K |
2024 Q2
9 quarters
|
|
Similar funds
Qube Research & Technologies (QRT)'s Q3 2026 Portfolio in Review
As of Q3 2026, Qube Research & Technologies (QRT) held 4,268 positions worth $123B, up 14% from $108B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Qube Research & Technologies (QRT) deployed $13.6B of net new capital in Q3 2026, opening 862 new positions and adding to 1,394 existing holdings. Its largest new stake was Caterpillar: 753,166 shares worth $611M.
By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1B trimmed.
- Qube Research & Technologies (QRT)'s largest Q3 2026 buy was Caterpillar: 753,166 shares worth $611M.
- Qube Research & Technologies (QRT) added most to Warner Bros in Q3 2026, an estimated $1.31B increase.
- Qube Research & Technologies (QRT)'s biggest Q3 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1B.
- Qube Research & Technologies (QRT) fully exited Intercontinental Exchange in Q3 2026, selling an estimated $490M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $123B portfolio in Q3 2026.
- Qube Research & Technologies (QRT) opened 862 new positions and closed 641 in Q3 2026.
- Qube Research & Technologies (QRT)'s portfolio value rose 14% quarter-over-quarter to $123B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.